| Financial Year |
March 31 2022 |
| Monetary Funds |
86,784,902.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
23,193,512.18 |
| Advances to Suppliers |
15,115,745.47 |
| Other Receivables |
7,234,799.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
691,567.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,970,687.07 |
| Total Current Assets |
134,991,213.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,531,392.40 |
| Investment Properties |
13,092,003.94 |
| Fixed Assetes |
11,496,777.80 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
852,000.00 |
| Sub-Total of Non-Current Assets |
110,536,017.39 |
| Total Assets |
245,527,231.14 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
4,010,907.01 |
| Accounts Received In Advance |
1,751,896.79 |
| Employee Compensation Payable |
5,275,881.26 |
| Taxes Payable |
-- |
| Interest Payable |
-- |
| Dividend Payable |
3,042,718.48 |
| Other payables |
18,688,953.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
968,481.30 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
30,696,119.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,595,361.95 |
| Total Liabilities |
32,291,481.45 |
| Paid-In Capital(Or Share Stock) |
579,194,925.00 |
| Capital Surplus |
38,911,795.07 |
| Surplus Reserve |
84,916,187.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-491,349,742.38 |
| Minority Stockholder's Interest |
1,562,584.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
211,673,164.86 |
| Owner's Equity（Stockholder's Equity） |
213,235,749.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
245,527,231.14 |
